Author: Selina McKee

The National Health Service is delving deeper into the digital era with the launch of Summary Care Records in London this week, which are designed to provide healthcare professionals with immediate access to patients’ medical information.

Bristol-Myers Squibb and Novartis are facing a giant hurdle in getting their respective leukaemia drugs Sprycel and Tasigna funded by the National Health Service, after the cost-watchdog issued an amber light for their use.

The trend of year-on-year declines in National Health Service productivity seems to have been turned around as more patients are being treated at a lower cost, an analysis by the Audit Commission has revealed.

The Department of Health has launched a new consultation over whether patients should be given legal rights to maximum waiting times and health checks on the National Health Service.

French drugmaker Sanofi-Aventis and US group Regeneron Pharmaceuticals have extended their global partnership to discover, develop, and commercialise fully-human therapeutic monoclonal antibodies.